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Mouse models have shown the importance of acidic mam-
malian chitinase activity in settings of chitin exposure and
allergic inflammation. However, little is known regarding
genetic regulation of AMCase enzymatic activity in human
allergic diseases. Resequencing the AMCase gene exons we
identified 8 non-synonymous single nucleotide polymor-
phisms including three novel variants (A290G, G296A,
G339T) near the gene area coding for the enzyme active site,
all in linkage disequilibrium. AMCase protein isoforms,
encoded by two gene-wide haplotypes, and differentiated by
these three single nucleotide polymorphisms, were recombi-
nantly expressed and purified. Biochemical analysis revealed
the isoform encoded by the variant haplotype displayed a dis-
tinct pH profile exhibiting greater retention of chitinase
activity at acidic and basic pH values. Determination of abso-
lute kinetic activity found the variant isoform encoded by the
variant haplotype was 4-, 2.5-, and 10-fold more active than
the wild type AMCase isoform at pH 2.2, 4.6, and 7.0, respec-
tively. Modeling of the AMCase isoforms revealed positional
changes in amino acids critical for both pH specificity and
substrate binding. Genetic association analyses of AMCase
haplotypes for asthma revealed significant protective associ-
ations between the variant haplotype in several asthma
cohorts. The structural, kinetic, and genetic data regarding
the AMCase isoforms are consistent with the Th2-priming
effects of environmental chitin and a role for AMCase in neg-
atively regulating this stimulus.
Chitin, a linear polymer of the sugarN-acetylglucosamine, is
ubiquitous in nature and comprises a structural component in
the cell wall of fungi, the exoskeleton of arthropods such as
insects and crustaceans, and in the eggs and pharyngeal organs
of parasitic nematodes (1–5). Chitinases are evolutionarily
ancient enzymes that hydrolytically cleave the chitin polymer
into di- and trisaccharides. Chitinases serve functionally
diverse roles across species, including nutrient scavenging,
structural remodeling of chitin constituents, parasitism, and
innate immunity (6, 7).
Despite the absence of endogenous chitin, humans express
two active chitinases, designated acidic mammalian chitinase
(AMCase)2 and chitotriosidase (6). Chitotriosidase (CHIT1) is
expressed by phagocytic cells in humans and extremely high
levels are seen in lysosomal storage diseases, such as Gaucher
disease (8). The high frequency of a null duplication polymor-
phism in the CHIT1 gene triggered the search for other lung
chitinases that may compensate for the loss of CHIT1 enzy-
matic activity. This search resulted in the discovery of the
AMCase enzyme in both mice and humans. The AMCase
enzyme has been suggested to be involved in asthma due to the
finding that its expression was strongly up-regulated in
response to sensitization and challenge in an ovalbuminmouse
model of asthma. The expression of AMCase was found to be
induced by interleukin-13, a cytokine implicated in many of
the effects of human asthma (9, 10). Moreover, the chitinase
activity of AMCase was found to be causative in allergic inflam-
mation, as inhibition of AMCase activity greatly reduced Th2-
dependent airway inflammation and bronchial hyperrespon-
siveness in these mice (10). Intriguingly, this report also found
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AMCase to be induced strongly in both lung epithelial cells and
macrophages among fatal asthmatics (10). However, a more
recent report implicated chitin itself as a pattern recognition
molecule stimulating the tissue accumulation of innate
immune cells associated with asthma, such as eosinophils and
basophils (11). Importantly, this study found pretreatment of
the polymeric chitin with recombinant AMCase attenuated the
inflammatory effects of chitin (11). The results were confirmed
in vivo, showing a strong reduction in the inflammatory effects
of chitin in mice overexpressing AMCase in the airway epithe-
lium (11).
Despite the observed importance of chitinase activity in
animal models of asthma, little is known regarding regula-
tion of chitinase activity in human disease. The only genetic
studies of the AMCase gene, conducted in Indian and Ger-
man populations, have found the gene to be polymorphic
and observed significant associations between several poly-
morphisms and asthma disease status (12, 13). In fact, the
Indian study found the associated promoter polymorphisms
significantly affected transcription levels in vitro (13). The vari-
ants associated with asthma in the German study result in
amino acid changes, raising the possibility that codingAMCase
polymorphismsmay influence chitinase activity and potentially
disease risk (12). Biochemical analysis of the human AMCase
protein has revealed the enzyme does cleave chitin substrates
and that its activity ismodified by pHand salt concentration (7).
In this report we have explored the role that genetic variation
plays in regulation of AMCase enzymatic activity. Herein we
describe all common coding variations and haplotypes in the
human AMCase gene. We have biochemically characterized
two haplotypic isoforms of the AMCase enzyme differing in
amino acids close to the enzyme active site and assessed their
effect on the three-dimensional structure of the enzyme. Last,
we explored whether the gain-of-function haplotype discov-
ered was associated with asthma risk in several United States
ethnic groups.
EXPERIMENTAL PROCEDURES
AMCase Sequencing, Linkage Disequilibrium, and Haplotype
Analysis
All AMCase exons (12) and exon-intron boundaries (20 bp
from either end of the exon) were sequenced in a SNP Discov-
ery panel, which contains 72 subjects with asthma who self-
identified asAfricanAmerican, PuertoRican, orMexican.Vari-
ants identified, sequencing details, and primers are listed in the
supplemental data (Tables S1 and S2). Linkage disequilibrium
patterns were determined by using the r2 statistic, using the
program haploview (Table S3) (14). Haplotypes and their fre-
quencies were determined with the program HAPSTAT (15).
AMCase Expression Plasmid Cloning
The full-length AMCase cDNA was fused to an Fc purifica-
tion tag and cloned into the pMIB-V5-His-(A) vector (Invitro-
gen). The Fc purification tag did not contain the hinge region to
prevent dimerization of the proteins. Successive rounds of in
vitro mutagenesis were conducted on the AMCase expression
construct using the Stratagene QuikChange kit, to generate
both the variant and wild type AMCase haplotypes. Detailed
methods are listed in the supplemental data. PCR cloning and
mutagenesis primers for all of these cloning and mutagenesis
steps are contained in Tables S4 and S5.
Expression and Purification
In parallel, High Five insect cells (Invitrogen) were trans-
fectedwith the pMIB-V5-His-(A)-AMCase-Fc vectors contain-
ing both the variant (GATGAGCG) and wild type (AGG-
GAATT) haplotypes, and mock transfection. Blasticidin was
used to select for stable cell lines over a 3-week period. These
cell lines were grown in culture dishes for 5 days and AMCase
was purified from the supernatants using Immobilized Protein
G resin (Pierce Biotechnology). A detailed purification protocol
is described under the supplemental data. Eluted fractions were
run on SDS-PAGE gels to ensure the purity of the AMCase
protein. AMCase protein concentration was determined with
the Micro BCA assay (Pierce Biotechnology) according to the
manufacturer’s instructions.
AMCase Enzymatic Assays
General—AMCase enzymatic activity was determined using
the synthetic chitin substrate 4-MU-(4-deoxy)chitobiose (16).
All enzymatic reactions for both determination of optimumpH
and kinetic parameters were conducted in a volume of 100 l,
containing 100 ng of AMCase protein inMcIlvaine’s buffer. All
reactions were conducted in triplicate in 96-well fluorescent
spectroscopy plates (Sigma) with 4-methylumbelliferone also
loaded as a standard. Reactions for both pH and kinetic assays
were incubated in a SpectraMax Gemini XS fluorescence plate
reader for 20 min at 37 °C. Reactions were stopped by the addi-
tion of 120 l of 1 M glycine/NaOH, pH 10.5, to reaction wells.
Plates were then immediately read on the SpectraMax fluorom-
eter at an excitation wavelength of 365 nm and an emission
wavelength of 460 nm.
AMCase pH Assays—We tested the enzymatic activity of
both AMCase isoforms in McIlvaine buffer at pH values of 2.2,
2.6, 3.0, 3.4, 3.8, 4.2, 4.6, 5.0, 5.4, 6.0, 7.0, and 8.0 to determine
the AMCase pH profiles. Enzymatic activity at all pH values
were tested at a substrate concentration of 75 M.
AMCase Kinetic Reactions—Michaelis-Menten kinetic curves
were generated by performing AMCase enzymatic reactions
with the substrate 4-MU-(4-deoxy)chitobiose at concentra-
tions of 10, 25, 50, 75, 100, 150, and 200 M. Kinetic assays for
both isoforms were performed at pH values of 2.2, 4.6, and 7.0.
Reactions were conducted as described under “General.”
AMCase Enzymatic Data Analysis—Enzymatic activity in
pH profiles was displayed as a percent of activity at the pH
where the isoform was most active (pH 4.6 for both iso-
forms). The pH profiles displayed in Fig. 3A are the result of
a single experiment representative of at least two independ-
ent experiments.
For determination of enzyme velocities the mean fluores-
cence units detected from the triplicate assays were converted
to picomoles of product produced by extrapolation using the
4-MU standard curves generated on each plate, and divided by
reaction time and enzyme amount. Enzyme velocities divided
by the amount of enzyme in the reactionwere plotted versus the
substrate concentration and fitted to the Michaelis-Menten
Haplotypic Effects on AMCase Enzymatic Activity
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equation by non-linear regression to determine the kinetic
parameters,Km andKcat of each experiment, using the program
Graphpad Prism 4.0. The kinetic parameters listed herein are
the mean of four independent experiments for the analysis at
pH 4.6 and two independent experiments for the analysis at pH
2.2 and 7.0. Statistical comparison of the kinetic parameterswas
by two-sample two-tailed t test assuming equal variances.
Modeling of theWild Type and Variant AMCase Isoforms
The recombinant protein used to generate the AMCase
structure contains the variant haplotype amino acid changes
(17). To investigate the influence of these changes on the overall
structure we generated initial models of AMCase using the
nativeAMCase crystal structure ProteinDatat Bank code 3FXY
(A chain resolution, 2.0 Å) and the SWISSPROT server (18). To
generate the wild type model the aspartate at position 45 was
converted to an asparagine, asparagine at position 47 was con-
verted to an aspartate, and the methionine at position 61 was
converted to an arginine. Both the native and modified model
were subjected to energy minimization using the macromolec-
ular modeling package CHARMMing tool in the default set-
tings (19). The structural implications were analyzed using
MacPyMOL.
Genetic Study Populations and Genotyping Analysis
SNPs G339T, G461A, A531G, G1172A, T1218G, and
G1452T were genotyped in the Study of African Americans,
Asthma, Genes, and Environments (SAGE) and Genetics of
Asthma in Latino Americans (GALA) study subjects. The
SAGE study includes 264 asthmatic cases and 176 matched
controls, recruited in the San Francisco Bay Area. TheGenetics
of Asthma in Latino Americans (GALA) study recruited 301
Mexican and 399 Puerto Rican asthmatics (probands) and their
biologic parents from 4 different clinical sites: Mexico City/San
Francisco (Mexican) and Puerto Rico/New York (Puerto
Ricans). African American asthmatic cases from the Chicago
Initiative to Raise Asthma Equity (CHIRAH) and the Asthma
Clinical Research Network (ACRN) cohorts were genotyped
for the G339T AMCase SNP. In addition, we genotyped the
G339T AMCase SNP in 259 African American (asthmatic
cases 61, controls 198) and 456 Latino (asthmatic cases
138, Controls 318) subjects from theChildren’s Health Study
(CHS). All genotyping methods and primers are described
under supplemental data (Table S6). All study groups are
described in detail in the online supplement with characteris-
tics listed in Tables S7 and S8. Local Institutional Review
Boards approved all the studies, and all subjects provided writ-
ten, age-appropriate informed consent or assent.
Genetic Statistical Analyses
The 2 goodness-of-fit test was used to determine whether
the individual AMCase SNPs were under Hardy Weinberg
equilibrium. All SNPs genotyped conformed to Hardy Wein-
berg equilibrium (p  0.01) in all five study groups tested.
Standard logistic regression was used to test association
between AMCase SNP alleles and asthma disease status in the
SAGE, CHIRAH, and ACRN cohorts. Age and gender were
both included as covariates in the logistic regression models.
Additionally, individual ancestry estimates (see supplemental
data) were covariates in the SAGE and CHIRAH analyses. All
statistical analyses in the three populations were performed
using STATA 8.0 S/E statistical software (College Station, TX).
FBAT was used to assess the association between individual
SNPs with asthma in the GALA families (20). Replication anal-
ysis in the CHS subjects was performed by logistic regression
assuming an additive geneticmodel. Development of themodel
and covariates included are described under the supplemental
data. CHS analysis was performed in SAS version 9.1 (SAS
Institute Inc., Cary, NC).
RESULTS
Identification of Common AMCase Coding Variants and
LinkageDisequilibriumPatterns—To identify common genetic
variants in theAMCase gene thatmay influence chitinase activ-
ity we resequenced all 12 AMCase exons in three diverse pop-
ulations: African Americans, Puerto Ricans, andMexicans.We
identified 21 variants including four 5-untranslated region
variants, nine non-synonymous SNPs, four synonymous SNPs,
a 3-untranslated region SNP, and three intronic SNPs, of
which ninewere novel (Table S1). Among the non-synonymous
SNPs there were eight variants that were common (5% allele
frequency) to all three racial groups SNPs: A290G, N45D;
G296A, D47N; G339T, R61M; G461A, G102R; A531G, K125R;
G1172A, V339I; T1218C, F354S; and G1452T, G432V (Fig. 1).
Minimal linkage disequilibrium was exhibited between these
variants with the exception of three novel SNPs, A290G,
G296A, and G339T (Table S2). These three SNPs were inher-
ited as a linkage disequilibrium block (pairwise r2  1.0) in all
populations.
Gene-wide AMCase Haplotypes—To help determine which
amino acid changes may be critical to enzymatic activity we
determined their locationwithin theAMCase protein domains.
As observed from Fig. 2, the AMCase protein is composed of an
N-terminal signal peptide, followed by the glycosyl hydrolase
18 domain, containing a highly conserved active site, linked to
the chitin binding domain by a hinge region. Variants localized
both within the chitin-binding and glycosyl hydrolase domains.
Most interestingly, the three linked amino acid changes, R61M,
N45D, andD47N, clustered in the glycosyl hydrolase domain in
A290G Asn45Asp 
9%, 13%, 26%
G296A Asp47Asn 
9%, 13%, 26%
G339T Arg61Met 
9%, 13%, 26%
G461A Gly102Arg 
4%, 10%, 15%
A531G Lys125Arg 
6%, 10%, 5%
G1172A Val339Ile  
64%, 45%, 21%
T1218C Phe354Ser 
30%, 39%, 39%
G1452T Gly432Val  
64%, 45%, 22%
FIGURE 1. The structure of the human AMCase gene, with accompanying
common non-synonymous SNPs present among Mexicans, Puerto
Ricans, and African Americans. Exons are identified by blue and red block
structures and numbered accordingly. The red portion of exons represent
untranslated regions and the blue represent the coding portion of exons. All
variant mRNA and amino acid positions are reported with regard to mRNA
sequence uc001eas.1 (UCSC Genome Browser). Percentages listed refer to
minor allele frequencies in Mexicans, Puerto Ricans, and African Americans,
respectively. The minor allele and amino acid is listed second.
Haplotypic Effects on AMCase Enzymatic Activity
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very close proximity to the active site residues. To determine
the naturally occurring gene-wide AMCase haplotypes we
genotyped these three SNPs and the other 5 coding AMCase
SNPs in 176 African Americans, 602Mexicans, and 798 Puerto
Rican subjects. We then used these genotype calls to infer the
AMCase gene-wide haplotypes using haplotype software Hap-
stat.We observed 6 different common (5% frequency) haplo-
types in African Americans and Latinos (Fig. 2). Interestingly,
the variant alleles of the three linked variants near the AMCase
active site (A290G, G296A, and G339T) only occurred on one
of the six haplotype backgrounds, GATGAGCG. We hypothe-
sized that the naturally occurring AMCase protein isoform
encoded for by the GATGAGCG haplotype would display dif-
ferential chitinase activity in comparison to any one of the other
AMCase haplotypes, which contain the wild type alleles of the
three variants in close proximity to the active site. As a compar-
ison to the GATGAGCG haplotype, we selected themost com-
mon of these wild type allele containing haplotypes, AGG-
GAATT (African American, 18.4%, Mexican, 44.1%, Puerto
Ricans, 63.9%), for expression and enzymatic analyses.
Biochemical Analysis of Variant Human AMCase Isoforms—
Using an insect cell expression system and Fc affinity purifi-
cation tag we expressed and purified both isoforms of the
AMCase protein. Chitinase activity was assessed by enzy-
matic digestion of a synthetic
chitin substrate. Although chitinase
activity is commonly determined
using fluorogenic substrates, such as
4-methylumbelliferyl--N,N-di-
acetylchitobioside (4-MU-chitobio-
side: two N-acetylglucoamine sug-
ars linked to the fluorescent 4-MU
molecule), AMCase enzymatic
activity is inhibited at high substrate
concentrations, thus precluding
accurate determination of kinetic
parameters with these substrates
(16). Therefore, we used a chemi-
cally altered version of 4-MU-chito-
bioside, 4-MU-(4-deoxy)-chito-
biose, which has been modified to
prevent substrate inhibition, thus
allowing accurate determination of
enzyme kinetics (16). Previous work
has shown the optimal pH of
AMCase enzymatic activity is 4.6,
with sharply declining activity at
more acidic and basic pH values (7).
We determined the pH profile of
enzymatic activity for both isoforms
of the protein over a range of pHval-
ues from 2.2 to 8.0, and corrobo-
rated that both isoforms display
optimal enzymatic activity at pH 4.6
(7). We found that the variant iso-
form (GATGAGCG) retained near
optimal activity at acidic pH values
(Fig. 3A). In contrast, enzymatic
activity of the wild type isoform (AGGGAATT) declined
sharply with decreasing pH, as previously reported for AMCase
(Fig. 3A) (7). Furthermore, the variant isoform maintains 57
and 28% of optimal enzymatic activity at pH values of 6.0 and
7.0, respectively, whereas the wild type isoform has only 31% of
optimal enzymatic activity at pH 6.0 and is essentially devoid of
activity at pH 7.0.
We next kinetically characterized the AMCase isoforms to
identify any differences in absolute enzyme activity between the
variant andwild type AMCase isoforms. To conduct the kinetic
analysis we selected three pH values, which reflect the three pH
environments likely to contain AMCase in the human body: 1)
pH 2.2, reflecting the stomach acidity where AMCase is highly
expressed; 2) pH 4.6, reflecting the pH of lysosomes where
some AMCase likely resides; and 3) pH 7.0, reflecting the pH of
the airway lumen. AMCase isoforms were tested at a range
of substrate concentrations from 10 to 200M, and data tightly
fit the Michaelis-Menten equation at all pH values for both
isoforms (r2  0.95). The kinetic parameters determined for
the twoAMCase isoforms at pH2.2 revealed a significant increase
in enzymatic activity of the variant isoform versus the wild type
isoform at both subsaturating (variant Km  48 M, wild type
Km 171.6 M, p 1.8 103) and saturating substrate con-
centrations (variant Kcat 1.43 s1, wild type Kcat 0.34 s1,
FIGURE 2.AMCase protein domain structure and commonhaplotypeswith frequencies in AfricanAmer-
icans, Puerto Ricans, and Mexicans. Haplotypes are defined as variant or wild type depending on whether
they contained theminor ormajor alleles of the three linkedSNPs (shown in red) in closeproximity to the active
site (A290G, G296A, G339T), respectively. The haplotype alleles for SNPs A290G and G296A are inferred based
on the linkage disequilibriumpatterns defined in resequencing. Haplotypes frequencies reported are for SAGE
controls and GALA parents.
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p  1.9  103) (Fig. 3B, Table 1). The variant isoform was
similarly more active than the wild type isoform at pH 4.6 (var-
iant Kcat 1.83 s1, Km 30.18 M; wild type Kcat 0.71 s1,
Km  70.3 M, p  6.2  108 and 4.6  104, respectively)
(Fig. 3C, Table 1). Although enzymatic activity for the variant
isoformwas considerably lower at pH7.0 (Kcat 0.56 s1,Km
71.75 M), activity was barely detectable for the wild type iso-
form (Kcat 0.05 s1, Km 134 M; Kcat, p 8.5 103, Km,
p 5.4 103) (Fig. 3D, Table 1).
Three-dimensional Modeling of Variant AMCase Isoforms—
The human AMCase crystal structure has recently been pub-
lished (17). The recombinant protein used to generate this
structure contains the variant haplotype amino acid changes.
To analyze the consequence of these changes we generated
AMCase models by introducing the relevant wild type amino
acids (see “Experimental Procedures”). Subsequent energy
minimization resulted in two models that were used to analyze
the effects of these amino acid changes. Structural comparison
indicated that the overall protein fold is not altered as indicated
by the low root mean square deviation (0.113 Å) of the back-
bone C atoms.
According to Olland and co-workers (17), a triad of polar
residues (His-208, His-269, and Arg-145) control pH specific-
ity, whereas residues Trp-99, Asn-100, Asp-138, Glu-140, Tyr-
212, Asp-213, and Trp-360 are implicated in interaction with
the substrate and catalysis. Superpositioning of the two energy-
minimized models indicates slight structural changes for some
of these amino acids (Fig. 4). For example, His-269 andArg-145
show a small change in position, whereas the position of His-
208 is not changed. Because these residues are reported to play
a role in pH specificity, one could envision that a positional
rearrangement of these residues alter the pH specificity of the
enzyme (17). In the variant haplotype, His-269 forms a hydro-
gen bond with Asp-213 and thereby influences the pKa value of
the Asp-138/Glu-140 system (17). A slight change in the posi-
tion of the His-269 (rotation) in the wild type structure renders
this hydrogen bonding less efficient, thereby changing the pKa
of the Asp-138/Glu-140 system. Moreover, Arg-145 also influ-
ences the pKa of the Asp-138/Glu-140 system, by hydrogen
bonding with the active site residues in a manner similar to
His-269. Structural changes of Arg-145 will also affect this
interaction.
Besides these positional changes in the triad of polar resi-
dues, the positions of some of the residues interacting with the
substrate are slightly changed (Trp-99, Asn-100, and Glu-140,
see Fig. 4) also, whereas the positions of Asp-138, Tyr-212, Asp-
213, and Trp-360 do not change significantly. Changes in the
positions of these amino acids might influence the substrate
binding and/or stabilization of the transition state intermedi-
ate. Altogether these structural changes support the observed
FIGURE 3. pH and kinetic characterization of AMCase isoforms. AMCase
activity was determined using the synthetic chitin substrate 4-MU-(4-deoxy)-
chitobiose. A, pH activity profile of variant (GATGAGCG) and wild type (AGG-
GAATT) AMCase isoforms. Activity at each pH is expressed as a percentage of
activity at optimum pH. Michaelis-Menten kinetic profiles of AMCase iso-
forms. B, assays conducted at pH 2.2. C, assays conducted at pH 4.6. D, assays
conducted at pH7.0. Substrate concentrations testedwere 10, 25, 50, 75, 100,
150, and 200 M. Curves were fit to data by nonlinear regression using the
Michaelis-Menten equation. All graph points are themean of triplicatemeas-
urements and representative of multiple experiments.
TABLE 1
Summary of the Michaelis-Menton kinetic parameters for AMcase
isoforms at physiological pH values
Kinetic parameters are the best fit values fromnon-linear regression of datawith the
Michaelis-Menton equation. All data points are the mean of triplicates measure-
ments, and kinetic parameters are the mean of at least two independent experi-
ments. Numbers in parentheses are standard deviation of kinetic parameters. Sta-
tistical comparison of kinetic parameters conducted by Student’s t test.
AMCase haplotypes
Kinetic parameters
Kcat p value Km p value
pH 2.2
Variant GATGAGCG 1.43 (0.04) 1.9 103 48.01 (1.93) 1.8 103
Wild type AGGGAATT 0.34 (0.05) 171.6 (7.21)
pH 4.6
Variant GATGAGCG 1.83 (0.06) 6.2 108 30.18 (1.34) 4.6 104
Wild type AGGGAATT 0.71 (0.03) 70.3 (5.63)
pH 7.0
Variant GATGAGCG 0.56 (0.07) 8.5 103 71.75 (5.46) 5.4 103
Wild type AGGGAATT 0.05 (0.01) 134 (3.53)
FIGURE 4. Structural implications of the three amino acid changes in the
variant isoform compared with wild type AMCase. The wild type AMCase
structure is shown in black, the variant isoform structure in red. Only the side
chains of those amino acids that are changed in the variant structure com-
paredwithwild type and that are implicated in either binding/catalysis or pH
specificity (see text) are depicted as sticks (black, wild type; red, variant iso-
form). The side chains of the three amino acids that aremutated in the variant
isoform are also indicated (Asn/Asp-45, Asp/Asn-47, and Arg/Met-61).
Haplotypic Effects on AMCase Enzymatic Activity
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differences in pH specificity and the overall alteration in cata-
lytic activity of the variant human AMCase isoform.
AsthmaAssociationAnalysis of AMCase SNPs—Based on the
large gain in enzymatic activity conferred by the variant genetic
isoform of the AMCase protein, we hypothesized that the SNP
tagging the haplotype, which encoded this variant AMCase
protein (G339T), may be associated with asthma. We geno-
typed this and the other five non-synonymous AMCase SNPs
(G461A, A531G, G1172A, T1218G, G1452T) in the SAGE
study subjects (Table S7). The SAGE study includes 264 asth-
matic cases and 176 healthy controls all self-identified as Afri-
can Americans. Allele frequencies in SAGE cases and controls
are displayed in Table 2. Using logistic regression the only SNP
to achieve statistically significant association with asthma dis-
ease status was the SNP tagging the gain-of-function AMCase
haplotype, G339T (Table 2). The minor T allele of SNP G339T
was present at a frequency of 25.9% in the controls and 16.8% in
asthmatic cases, revealing an association with asthma protec-
tion (odds ratio  0.57, 95% confidence interval  0.38–0.83,
p  0.004). To confirm the lower allele frequency of SNP
G339T among asthmatics we genotyped two additional in-
dependent groups of African American asthmatic cases. In
African Americans with asthma from the CHIRAH study (n
321) and ACRN study (n 334) we observed allele frequencies
of 16.7 and 18.2%, respectively, nearly identical to that of SAGE
asthmatic cases (Table S7). Comparing allele frequencies of the
G339T SNP in CHIRAH and ACRN asthmatic cases to SAGE
controls by logistic regression resulted in statistically signifi-
cant associations with asthma protection among both studies
(0.62 (0.43–0.89), p  0.01; 0.64 (0.47–0.88), p  0.005),
respectively (Table 2).We also tested the same 6 SNPs screened
among African Americans for association with asthma in the
GALA family based trios study (trios n 700) by transmission
disequilibrium test (Table S7). The GALA study includes both
foreign andUnited States residentMexicans and Puerto Ricans
recruited to allow determination of whether genetic effect
modification occurs by ethnicity or immigration status. Ana-
lyzing the GALA cohort stratified by ethnicity the only signifi-
cant association was with SNPA531G (p 0.03) among Puerto
Ricans, but not Mexicans (see Table S9). We did not observe a
significant association between SNP G339T and asthma in
either Mexican or Puerto Rican trios. However, examining the
cohort stratified by immigration status we found significant
undertransmission (indicating protective status) of the 339 T
allele among Latino Americans (p 0.04), but not foreign Lati-
nos (p  0.94). These results replicate both the presence and
direction of the SNP G339T association observed in African
Americans, as the 339 T allele is observed to be protective in
bothUnited States resident populations. To further explore the
broader applicability of our association between the gain-of-
function AMCase haplotype and asthma protection we tested
theG339T tagging SNP in an additional asthmatic case-control
group of African American (n  259) and Latino (n  476)
children recruited as part of the Children’s Health Study from
12 Southern California communities (21–23). The G339T
SNP was associated with asthma protection among Latino
subjects (p  0.02), replicating the genetic association
observed among the GALA study Latinos. However, the
G339T SNP was not associated among the African American
subjects from the CHS cohort. In total our genetic results
indicate that the gain-of-function AMCase haplotype is
associated with asthma protection in some populations.
DISCUSSION
The enzymatic activity of AMCase has been shown to be
critical in the regulation of pulmonary Th2 inflammation in
both murine models exposed and unexposed to polymeric
chitin. Based on the importance of AMCase enzymatic activity
in these processes we have explored the role of common coding
polymorphisms in the human AMCase gene on both enzyme
structure and function with subsequent determination of their
effect on asthma disease risk. Our comprehensive resequencing
of all coding portions of the AMCase gene has revealed the
highly polymorphic nature of the gene, as we found 8 amino
acid changing (non-synonymous) variants with a frequency of
at least 5% in multiple United States ethnic populations.
Through haplotype analysis we determined that these SNPs
associate to form 6 common gene-wide AMCase haplotypes
that code for the different AMCase protein isoforms. One of
these haplotypes contained the variant alleles of three linked
SNPs located in close proximity to the catalytic site of the
AMCase protein. Biochemical comparison of the variant iso-
form (containing variants in close proximity to the active site)
to the wild type isoform revealed the former to confer faster
kinetics of chitin cleavage and greater retention of enzymatic
activity over a wider range of pH values. These variant amino
TABLE 2
Allelic test of association between AMCase SNPs and asthma disease status among African American subjects
Allele frequencies reported are for the second allele listed. Odds ratios (OR), 95% confidence intervals (95% C.I.), and p values (p) were generated from logistic regression
models adjusting for age and gender (and % ancestry among SAGE and CHIRAH subjects). The CHIRAH and ACRN analysis used the SAGE controls.
SNP Allele frequency OR (95% C.I.) pSAGE cases (n 264) CHIRAH cases (n 321) ACRN cases (n 334) SAGE controls (n 176)
%
G339T 16.8 16.7 18.2 25.9 0.57 (0.38–0.83)a 0.004
0.62 (0.43–0.89)b 0.01
0.64 (0.47–0.88)c 0.005
G461A 17.1 14.5 1.15 (0.74–1.78) 0.525
A531G 4 4.6 0.90 (0.42–1.90) 0.774
G1172A 22.4 20.7 1.25 (0.85–1.83) 0.255
T1218C 32 39.2 0.81 (0.58–1.13) 0.216
G1452T 23.2 21.7 1.26 (0.86–1.84) 0.23
a Results for SAGE analysis.
b Results for CHIRAH analysis.
c Results for ACRN analysis.
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acids were found to alter the positioning of several key amino
acids involved in both pH specificity and substrate binding.
Interestingly, we found significant associations between the 339
T allele, which tags the variant isoform and protection from
asthma in three of four African American and both Latino
American study populations examined. These results provide
the first evidence that differential AMCase enzymatic activity
may modulate risk for human asthma.
This study represents the first biochemical and structural
analysis of the AMCase enzyme accounting for genetic varia-
tion in the AMCase gene. Although we only tested one of the
five wild type (with respect to the three linked variants tagged
by G339T) AMCase isoforms, the haplotype encoding this iso-
form is found at a high frequency in Mexicans (63.9%), Puerto
Ricans (44.1%), and African Americans (18%). The initial bio-
chemical analysis of human AMCase performed by Chou et al.
(7) reported a Kcat of 0.81 s1 and a Km of 61 M, which are
similar to the values we report for the wild type AMCase iso-
form (Kcat 0.71 s1, Km 70.3 M). In contrast we observed
significantly faster kinetic parameters for the variant AMCase
isoform (Kcat 1.83 s1,Km 31M), giving further credence
to the anomalous nature of the variant haplotype tested and
the representative nature of the wild type haplotype tested.
These results are supported by our modeling of the AMCase
isoforms, which reveals structural changes in three of the seven
substrate interacting amino acids (Trp-99, Asn-100, and Glu-
140), implying stabilization of the substrate may be responsible
for the observed differences in activity. Additionally, pH profile
results of Chou et al. (7)mirrored those determined for thewild
type isoform tested and differed dramatically from the variant
isoform at acidic and neutral pH values. Likewise, we found
hydrogen bonding between 2 of 3 of the polar residues critical
for AMCase pH specificity and active site residues to be less
efficient, resulting in changes in the pKa of the Asp-138/Glu-
140 system. These structural changes in the enzyme could be
responsible for both the isoform differences in pH specificity
and enzyme kinetics. It is interesting to note that the variant
alleles that define the variant isoform, A290G/G296A/G339T,
match those nucleotides reported at the corresponding posi-
tion in the murine Amcase gene. Similar to the variant human
isoform, murine Amcase exhibits excellent stability and kinetic
activity at lowpHvalues, supporting the role of these variants in
stabilizing the variant human AMCase isoform at low pH val-
ues (24).
Our genetic results represent the first screen of AMCase
genetic variation in Latino Americans or African Americans,
two groups with high asthma prevalence and morbidity. The
two prior human genetic studies ofAMCase, in Indian andGer-
man cohorts, both found significant associations between
AMCase SNPs and asthma disease status, increasing our confi-
dence that AMCase participates in human asthma pathogene-
sis. This study is the first to screen the full-lengthAMCase gene
(AF290004), whereas prior studies were based on a shorter ver-
sion of theAMCase transcript, lacking the fourth exon, which is
required for enzymatic activity. This fourth exon contains the
novel SNPs in the gain-of-function AMCase isoform that was
associated with asthma protection in both African Americans
and Latino Americans. To determine the broader applicability
of our genetic findings and increase confidence that our results
in the SAGE and GALA cohorts were not spurious findings we
attempted replication in multiple other genetic study groups.
The 339 T asthma case allele frequency in African Americans
was confirmed in two independent asthma case groups. Addi-
tionally, the association with SNP G339T in the GALA Latino
Americans was replicated in the Latino population from CHS.
However, we did not observe significant associations with
asthma and SNP G339T in the African American population
from CHS. This result may be a spurious finding based on the
small size of this study group (n  300) or could represent
differences in environmental effect modifiers in Southern ver-
susNorthern California. Further genetic studies will be needed
to confirm our results in African Americans. However, our
results are reinforced by the fact that the direction of associa-
tion was consistent across both ethnicities, multiple independ-
ent studies, and different study designs (case-control versus
family based trios). Future studies could likely provide more
insight with the inclusion of environmental factors intomodel-
ing, most notably environmental chitin exposure, which was
shown to be proinflammatory in the lungs of mice.
The dramatic increases in chitinase activity of the variant
AMCase isoform at pH 2.2 (4-fold higher) and 7.0 (10-fold
higher), corresponding to the pH of the lungs and stomach,
respectively, is especially relevant because the lumen of these
organs are exposed to exogenous chitin through inhalation and
ingestion. Indeed, some of the most common indoor allergens
in Western societies, such as the United States, include dust
mites, molds, and cockroaches, all chitin-containing organ-
isms. In fact, dust mite and cockroach feces, components of
house dust and a major source of allergy, are surrounded by a
chitinous peritrophic membrane (25, 26). Lack of childhood
exposure to bacterial products such as endotoxin has been asso-
ciated with risk of asthma in some studies, supporting the
hygiene hypothesis of allergic diseases. In this context, it is
noteworthy that chitinases produced by bacteria comprise an
important mechanism for degradation and turnover of the
massive amounts of chitin produced in marine environments
(27). The widespread use of anti-microbial cleaning products
and antibiotics in modern Western society may have inadvert-
ently contributed to the accumulation of environmental chitin
through suppression of bacterial populations producing chiti-
nases critical to environmental chitin degradation. Interest-
ingly, individuals employed in industries where exposure to
chitin would be anticipated to be high, such as shellfish proces-
sors, have a high prevalence of new onset asthma (28). The
development of asthma in these industries has been linked with
processing steps involving high pressure shell meat removal,
which produce vapors and particulate aerosols (28). In settings
of high environmental chitin burden it would prove beneficial
for subjects to produce a hyperfunctional AMCase enzyme
capable of degrading this inflammatory stimulus (see Fig. 5). In
this context we note our prior finding that chitotriosidase not
AMCase was the primary enzyme responsible for chitinase
activity in the bronchoalveolar lavage of asthmatics, smokers,
and healthy controls. In this work we found AMCase protein to
be overexpressed in asthmatic subjects, which is consistent
with our observations here, but the protein was expressed from
Haplotypic Effects on AMCase Enzymatic Activity
19656 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 29•JULY 17, 2009
 at W
A
LA
EU
S LIBRA
RY
 on M
ay 10, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
a splice variant of the AMCase gene resulting in a non-func-
tional protein. Differential splicing of theAMCaseRNAmay be
dependent on physiologic conditions within the lung. For
example, the asthmatic subjects in this study were all stable and
had mild disease at the time of sampling. Because AMCase
expression is strongly regulated by activeTh2 inflammation it is
very possible the active isoform predominates in severe asth-
matics and/or during asthma exacerbations. Furthermore, con-
sistent with the diseasemodel presented here, expression of the
active isoform could be acutely up-regulated by environmental
chitin exposures.
Intriguingly, the enhanced acidic pH activity of the protec-
tive isoform of AMCase may reflect improved activity in the
stomach, where the degradation of ingested polymeric environ-
mental chitin or chitin-containing microorganisms could lead
to modifications of the bowel commensal flora or to alterations
in immune responses to ingested allergens. Ingested polymeric
chitin has been observed to disrupt interactions with host pro-
teins involved in regulating bacterial adherence to the gastro-
intestinal epithelium, such as RegIII, and to be used as the
preferred energy source by certain gut bacteria (29, 30). Alter-
ations in intestinalmicroflora have been observed tomodify the
subsequent immune response to allergens in the lung in exper-
imental models, supporting this possibility (31).
In summary, we have identified a common genetic variant in
the AMCase gene, which results in an AMCase isoform that
displays significant enzymatic activity over a much wider pH
range, and exhibits dramatically enhanced kinetics of chitin
cleavage at all pH values relevant to AMCase expression in the
human body. In line with the observed differences in enzymatic
activity we found the three-dimensional model of the variant
enzyme to exhibit significant rotation in amino acid residues
critical for enzyme function. Finally, we find the haplotype
encoding this isoform to be associated with protection from
asthma in several United States ethnic populations. These
results raise the possibility that increased AMCase enzymatic
activity could be protective against the development of human
asthma, possibly through cleavage of inflammatory chitin poly-
mers. Further studies examining the population effects on
asthma and allergy of high environmental chitin exposure are
warranted to explore this hypothesis.
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